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Open access under the ElMemory persistence needs a new event of consolidation 12 h after the acquisition. We investigated the
role of the cholinergic activity on the persistence of memory. For this purpose, we performed the treat-
ments 9 or 12 h after acquisition and the memory tested 2 or 7 days after inhibitory avoidance (IA) train-
ing. Here we report that activity of medial septum, by transitorily inactivating this structure with
lidocaine 12 h after IA training, is essential for memory persistence at the 7th day, but not for the forma-
tion at the 2nd day. We also report that muscarinic and nicotinic cholinergic receptors of CA1 area are
engaged on memory persistence. Since scopolamine (mAChRs antagonist) and mecamylamine (nAChRs
blocker) infusions, 12 h post-training, demonstrated impairment on long term memory (LTM), persis-
tence on the 7th day but no effect on LTM formation was found on the 2nd day in the IA test. The same
effects were found with pirenzepine, an M1 antagonist. No effects on the formation and persistence of
memory on the 2nd and 7th days were demonstrated after DHbE infusions (nAChRs subtype antagonist
a4b2, a3b2). These ﬁndings suggest that mAChR and nAChR at the CA1 area, and also MS activation, are
required for the persistence of memory.
 2011 Elsevier Inc. Open access under the Elsevier OA license.1. Introduction
Persistence is the most characteristic attribute of long-term
memory (LTM) (Bekinschtein et al., 2007). It has been recently
reported that pharmacological treatment administered in the hip-
pocampus 12 h after the training episode impairs the persistence
of memory (Medina, Bekinschtein, Cammarota, & Izquierdo,
2008). Interestingly, there was no effect of the treatment when
the animals were tested 2 days after training, but effects emerge
at a much later 7-day retention interval. This observation implies
that processing takes place around 12 h following training which
is critical to the long-term persistence of the memory trace (Med-
ina et al., 2008).
A new event of protein synthesis on the persistence phase is
required for the establishment of remote memory, being the
brain-derived neurotrophic factor (BDNF) one of the most impor-
tant proteins in this event. The studies made by Bekinschtein
et al. (2007) and Bekinschtein and collaborators (2008) showed
that inhibition of the protein synthesis in rat hippocampus at 12,
but not at 9 h after acquisition, hinders the persistence of fear
memories (Bekinschtein et al., 2007, 2008). These reports gave riseiências, Instituto de Ciências
), Av Itália, Km 8, Rio Grande,
rros).
sevier OA license.to a new ﬁeld of study on the involvement of hippocampus on
memory persistence.
The role of cholinergic system on memory acquisition and con-
solidation is well demonstrated in several works using pharmaco-
logical methods (Bancroft & Levin, 2000; Barros, Ramirez, Dos Reis,
& Izquierdo, 2004; Barros, Ramirez, & Izquierdo, 2005; Fletcher,
Calhoun, Rapp, & Shapiro, 2006; Fletcher, Baxter, Guzowski,
Shapiro, & Rapp, 2007; Izquierdo, Barros, et al., 1998; Izquierdo,
Medina, et al., 1998b). Nevertheless few works addressed choliner-
gic inﬂuence on the maintenance of memory (Lecourtier et al.,
2010).
In this study we investigated the role of the cholinergic activity
on the persistence of memory. For this purpose, we performed the
treatments 9 or 12 h after the IA training and then had the animals
tested 2 or 7 days later. In this case, alterations on memory reten-
tion only 7 days after the training session caused by the administra-
tion of these cholinergic treatments, together with no alterations of
memory formation, as measured 2 days after training, would dem-
onstrate the involvement of cholinergic system on the persistence
of memory. To study the inﬂuence of muscarinic receptors, as well
as the inﬂuence of the speciﬁc muscarinic M1 receptor subtype on
memory persistence, we infused the blockers scopolamine and
pirezenpine in the hippocampus. The role of nicotinic cholinergic
receptors and the subtypes a4b2, a3b2 was also investigated. We
infused the blockersmecamelamine and DHBE in the hippocampus.
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memory persistence, through a transitory inactivation of this struc-
ture with lidocaine.2. Materials and methods
2.1. Subjects and surgery
The animal model used in this study was Rattus norvegicus, of
the Wistar strain. Male rats n = 320 (age 2–3 months; weight
250–280 g) were obtained from the breeding colony of Universid-
ade Federal do Rio Grande (Rio Grande, RS, Brazil). The animals
were kept in groups of ﬁve in each cage, with a 12 h light/dark cy-
cle, at a temperature of 22 C ± 1 C, with food and water ad libitum.
After a week of acclimation, the animals were submitted to ste-
reotaxic surgery for the implant of cannulae on the CA1 region of
the hippocampus or on the medial septum, under Ketamin
(62.5 mg/kg) and Xilazin (13 mg/kg) anesthesia. The guide cannu-
lae were ﬁxed with acrylic resin at 1 mm above of CA1 region of
dorsal hippocampus, according to the following coordinates: 4.3
anterior, 3.0 lateral, 1.8 ventral or in the medial septum region,
coordinates: 0.6 anterior, 0.0 lateral, 4.7 ventral according to
the atlas by Paxinos and Watson (2007) (Fig. 1). At the end of the
surgery, to prevent infections, the animals were treated with an
antibiotic association (Pentabiótico, Brazil). The study followed
all the ethical recommendations of the Brazilian Society of Aninals
Used (SBCAL).2.2. Drugs and infusion procedures
For experimental procedures, rats were distributed randomly in
groups according to the treatments. For the hippocampal infusion
on the CA1 region, the groups were divided in mecamylamine
9.82 mM, a general nAChR antagonist; DHbE 18 mM, a speciﬁc
a4b2/a3b2 mAChR antagonist; scopolamine 9.1 mM, a general
mAChR antagonist; Pirenzepine 100 mM, a speciﬁc M1 mAChR
antagonist, and the control groups were treated with saline solu-
tion. For the medial septum treatment, the groups were treated
with lidocaine HCl at 40 mg/ml infusion and the control groups
were treated with saline solution. In all groups 1 ll/cannulae was
infused according to the treatment. For the infusion procedure,
an infusion cannula was ﬁtted through the guide cannulae and
the infusions were performed with Hamilton microsyringe coupled
to the cannulae with a polyethylene tube. At the time of infusion,
infusion cannula protruded 1.0 mm beyond the guide cannula
and was aimed at the hippocampus CA1 area or medial septum.
All the treatments were performed at 9 or 12 h after IA test. All
drugs were obtained from Sigma Chemical Co, USA.2.3. Behavioral procedures
2.3.1. Inhibitory avoidance (IA)
After recovering from surgery, the animals were manipulated
for 3 days to avoid neophobia and then submitted to a one trial
step-down inhibitory avoidance test. The IA apparatus consists in
an acrylic box (50  25  25 cm), whose ﬂoor consists of parallel
stainless steel bars spaced 1.0 cm apart and a 5 cm wide platform
located beside, slightly above the steel bars. On the training sec-
tion, each animal was placed over the platform and, immediately
after stepping down with its four paws on the steel ﬂoor, the ani-
mal received three 0.7 mA, foot shock, lasting 1 s each. In the test
section no foot shock was applied and the platform step down
latencies were measured. Memory retention was tested 2 or 7 days
post-training, different groups of animals were used to the tests onthe 2nd and 7th day to avoid the extinction of memory (Bekinsch-
tein et al., 2007).2.3.2. Elevated plus maze
The animals were also submitted to an elevated plus-maze
(EPM), 2 or 7 days after the treatments, to determine if the drugs
had affected mobility, locomotion or pro- or anti-conﬂict behaviors
(Barros et al., 2004). The EPM apparatus consists of a central plat-
form, two open arms and two enclosed arms. Both open and en-
closed arms are disposed in opposition to each other. The maze
is located 50 cm above ﬂoor level and tests were carried out under
a dim red light. In this test the animals are place individually on the
central platform and the time spent and the total entries on both
open arms are recorded, during 5 min (Aguiar et al., 2006).2.4. Cannulae placements
Postmortem veriﬁcation of cannulae placements were per-
formed as previously described (Barros et al., 2004). Brieﬂy, 1 ll
of 4% methylene blue in saline solution was infused through the
cannulae and the animals were then sacriﬁced by decapitation
and had their brains stored in formalin for at least 48 h. The cannu-
lae placements, as veriﬁed by histological examination, were found
to be correct (within 1 mm of the intended sites) in 93% of the ani-
mals. Only the behavioral data from these animals were analyzed.2.5. Statistical analysis
Nonparametric statistic was used to analyze the inhibitory
avoidance results in test-sessions because a 180 s ceiling was
established. Data are expressed as median and interquartile ranges
(25/75). Test-session latency in the step-down inhibitory avoid-
ance task Kruskal–Wallis analysis of variance was followed by
Mann Whitney U test. On the EPM task parametric statistic was
used and statistical differences were tested through analysis of
variance ANOVA test followed by Newman–Keuls post-test. In all
comparisons, p < 0.05 was considered to indicate statistical
signiﬁcance.3. Results
To determine the role of cholinergic system on LTM persistence,
we performed a strong (0.7 mA) inhibitory avoidance training (IA)
to induce the formation of a persistent memory and then we tested
different cholinergic treatments on the CA1 region of the hippo-
campus. We also studied the involvement of or the medial septum
region, through its inactivation with lidocaine infusion. These re-
gions are implicated in early memory formation (Morris, Garrud,
Rawlins, & O’Keefe, 1982; Niewiadomska, Baksalerska-Pazera, &
Riedel, 2009). We ﬁrst analyzed whether cholinergic mAChRs are
involved on LTM persistence and therefore we tested the animals
2 or 7 days after training. Scopolamine (9.1 mM) infusion per-
formed at 12 h post-training on the CA1 region (Fig. 2B) caused
an impairment on LTM persistence 7 days post-training
(p = 0.0008, n = 10–12, vs. control, Mann Whitney U test), but no
impairment on LTM formation was found 2 days after training in
the IA test. We next analyzed the effect of mAChR M1 subtype
on LTM persistence with a 12 h post-training infusion of M1 antag-
onist pirenzepine (100 mM) in the CA1 region (Fig. 2B). Similarly to
the treatment with scopolamine, no alterations of LTM formation
at 2 days were observed and a hindered LTM persistence at 7 days
in IA test was found (p = 0.0003, n = 10–12, vs. control, MannWhit-
ney U test).
Fig. 1. Figure representing AP plane – 4.3 mm or 0.6 mm from bregma adapted from the Atlas of Paxinos and Watson (2007) indicating cannulae placements in the dorsal
hippocampus (A) or medial septum (B) (marked area represents average region of acceptance, dyed with 1 ll of 4% methylene blue).
Fig. 2. Cholinergic muscarinic receptors participate in memory persistence 12 h post-training. (A) Scopolamine or pirenzepine infusion into dorsal hippocampus 9 h after
training does not interfere on memory formation at 2 days test or memory persistence at 7 days test. (B) Scopolamine intrahippocampal infusion 12 h after IA training impairs
memory persistence at 7 days test, but spares memory formation 2 days after training. Moreover Intrahippocampal infusion of pirenzepine causes an impairment of memory
persistence 7 days, but does not alter memory 2 days after training. ⁄, p < 0.05, n = 10–12; vs. control 7 days. Data are expressed as median and interquartile ranges (25/75).
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IA, however memory formation and persistence remained unal-
tered (p = 0.2039, n = 9–11, Kruskal–Wallis test) (Fig. 2A).
Furthermore, nAChRs participation on memory persistence was
tested. nAChRs blocker, mecamylamine (9.82 mM) was infused
12 h post-training in the CA1 area (Fig. 3B), and it seems to have
blocked LTM persistence at the 7th day of the IA test (p = 0.0076,
n = 10–13, vs. control Mann Whitney U test). However LTM at 2nd
day of the test remained unaffected.We also investigated the partic-
ipation of a4b2/a3b2 nAChR in memory persistence with DHbE
(18 mM) infusions, 12 h post-training, at the CA1 area (Fig. 3B).
However no effects on the formation and persistence of memory
at the 2nd and 7th days respectively were demonstrated after DHbE
infusions. According to the mAChR blockade experiments, the infu-
sion of nAChR antagonists,mecamylamine andDhbE, performed 9 h
after training had no effects on LTM formation and persistence
(p = 0.5316, n = 9–11, Kruskal–Wallis test) (Fig. 3A).
Wenext analyzedmemory persistence for 9 or 12 hpost-training
infusion of lidocaine in an attempt to inactivate the medial septum.
We found that lidocaine infusion 12 h post-training impairs LTM
persistence, as observed 7 days after training in IA task (p = 0.0019,n = 10–11, vs. control MannWhitney U test), but leavesmemory in-
tact on 2 days test (Fig. 4B). Lidocaine infusion 9 h post-training
showed no effects on both 2nd and 7th day tests (p = 0.3930,
n = 7–9, Kruskal–Wallis test) (Fig. 4A). On the data regarding train-
ing session, the step-down latencies among the groups showed no
differences (data not shown) (p = 0.5628, Kruskal–Wallis test).
To verify the absence of any interference on locomotion or anx-
iety that the treatments might have caused on the subjects, we
performed the elevated plus maze test, 2 or 7 days after the infu-
sions. No alterations in the percentage of time spent in open arms
among the groups were found (p = 0.3930, One-way analysis of
variance) however the group tested with scopolamine 2 days after
the injection showed an increase of the total entries, suggesting a
slight locomotion alteration (p < 0.05, vs. control, Newman–Keuls
Test) (Table 1).4. Discussion
The present study attempts to correlate the cholinergic system
with the modulation of memory persistence, at the crucial time
Fig. 3. Cholinergic nicotinic receptors participate on memory persistence 12 h post-training in IA. (A) Mecamylamine or DHbE intrahippocampal infusion 9 h post-training in
IA does not interfere with memory formation on 2 days IA test or memory persistence on 7 days IA test. (B) Mecamylamine infusion on dorsal hippocampus 12 h post-training
blocks memory persistence at 7 days test in IA, but does not interfere in memory formation on 2 days post-training test. Infusions of DHbE 12 h post-training does not
interfere in memory retention on 2 or 7 days test. ⁄, p < 0.05, n = 10–13; vs. control 7 days. Data are expressed as median and interquartile ranges (25/75).
Fig. 4. Medial septum activation is required for memory persistence at 12 h post-training. (A) Infusion of lidocaine on medial septum 9 h post-training on IA does not
interfere in memory retention, as tested 2 or 7 days after training. (B) Lidocaine infusion on medial septum 12 h post-training impairs memory persistence 7 days after IA
training, but leaves memory retention intact on animals tested 2 days after IA training. ⁄, p < 0.05, n = 10–11; vs. control 7 days. Data are expressed as median and
interquartile ranges (25/75).
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memory retention, with no interference on its formation at 2 days,
when mAChR or the M1 subtype are blocked at 12 h post acquisi-
tion. Moreover, similar results are found when nAChR were also
blocked at this aforementioned time, the animals are able to form
the memory, but the retention decays over time. That demon-
strates that the activation of these receptors at this time is essen-
tial for the participation of the hippocampus on memory
persistence. Surprisingly, both a4b2 and a3b2 nAChR subtypes
did not interfere in LTM persistence, since the blockade of these
receptors 12 h after the acquisition does not impair memory for-
mation or its retention for several days. We then performed a tran-
sitory inactivation of medial septum nucleus (MS) 12 h post-
training. Normal memory formation was observed 2 days after
the acquisition, but its retention was impaired at 7 days. This
shows that the activation of this area, which contains a populationof cholinergic neurons projected towards the hippocampus, is, at
this critical period, essential for memory persistence.
(Niewiadomska et al., 2009). Therewith we demonstrated that
the cholinergic system is engaged in hippocampal activity for the
maintenance of fear memories.
Our results show that the treatments carried out 12 h after
acquisition did not interfere on memory formation. This data cor-
roborates with Bekinschtein et al. (2007), which states that this
time point of 12 h after training in IA is crucial for the persistence
of memory, not causing any interference whatsoever on memory
formation (Bekinschtein et al., 2007). Moreover, no inference, on
either formation or persistence of memory, was observed when
the anticholinergic treatments were administered 9 h post-
training. This reafﬁrms the ﬁndings of Rossato, Bevilaqua, Izquier-
do, Medina, and Cammarota (2009) about the dopaminergic
system, which is only implicated on the persistence of LTM at
Table 1
Results from the elevated plus-maze task performed 2 or 7 days after treatments.
Treatment Total entries % Time open arms
Control 2 days 10.3 ± 0.9 43.4 ± 4.7
Control 7 days 10.6 ± 0.9 33.9 ± 6.6
Scopolamine 2 days 17.0 ± 1.3* 51.8 ± 4.9
Scopolamine 7 days 11.7 ± 1.4 39.7 ± 4.0
Pirenzepine 2 days 14.1 ± 1.3 49.7 ± 5.0
Pirenzepine 7 days 10.7 ± 0.9 36.8 ± 4.6
Mecamylamine 2 days 12.2 ± 2.1 49.2 ± 6.1
Mecamylamine 7 days 13.8 ± 1.7 40.5 ± 5.4
DHbE 2 days 14.7 ± 1.1 36.6 ± 4.1
DHbE 7 days 11.7 ± 2.8 41.3 ± 3.9
Control MS 2 days 13.4 ± 1.2 37.9 ± 3.6
Control MS 7 days 11.2 ± 1.3 35.0 ± 4.8
Lidocaine MS 2 days 10.7 ± 1.6 41.5 ± 2.9
Lidocaine MS 7 days 11.8 ± 1.1 36.0 ± 6.5
* p < 0,05 n = 7–8 ; vs. control 2 days. Data are expressed as mean and SEM.
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sato et al., 2009). One aspect that should be considered is that the
treatments carried out 9 h after the IA training could also interfere
at the time point of 12 h, as the interval between the two time
points is relatively short. Still, in all treatments, no alterations to
the persistence of memory were observed. Hence, if this putative
interference did occur, it did not sufﬁce to alter the persistence
of memory.
The role of muscarinic receptors in synaptic plasticity and
behavior has been widely studied. The stimulation of these recep-
tors enhances LTP induction in vitro and also enhances LTP mainte-
nance in vivo in the CA1 region of hippocampus (Blitzer, Gil, &
Landau, 1990; Iga, Arisawa, Ise, Yasuda, & Takeshita, 1996). Also,
behavioral experiments have showed impairments on memory
consolidation with post-training infusions of muscarinic antago-
nists, while the administration of muscarinic agonists renders an
enhancement of memory formation (Jerusalinsky, Cerveñansky,
Walz, Bianchin, & Izquierdo, 1993). Studies have shown that M1
receptors facilitated LTP in the CA1 region, probably through PKC
induced potassium SK channels inhibition (Buchanan, Petrovic,
Chamberlain, Marrion, & Mellor, 2010). In addition, M1 and M3
mAChRs in the hippocampus, as well as PKC, are involved in fear
memory formation (Ferreira et al., 2003; Izquierdo et al., 2008).
Moreover, Berzaghi and collaborators’ (1993) ﬁndings show that
regulation of the expression of BDNF on hippocampus is highly
regulated by mAChR (Berzaghi et al. 1993).
Nicotinic receptors are widely expressed in the hippocampus,
being both pre and post-synaptic a7 subunits and post-synaptic
b2 subunits the most expressed ones (Fabian-Fine et al., 2001; Zar-
ei, Radcliffe, Chen, Patrick, & Dani, 1999). They participate on neu-
ronal plasticity in the hippocampus by boosting LTP and by
modifying neuronal protein transcription through CREB activation
and related cFOS induction (McKay, Placzek, & Dani, 2007). They
also participate in memory processes, as impairments on acquisi-
tion, consolidation and retrieval of LTM as well as working mem-
ory, after nonspeciﬁc and a4b2, a3b2 and a7 subtypes blockade,
have been reported (Barros et al., 2004; Barros et al., 2005; Nott
& Levin, 2006). Memory persistence impairment due to nonspeciﬁc
nAChR blockade on CA1 could be explained by the plasticity of the
neuronal modulation through these receptors. However, no signif-
icant effects of a4b2, a3b2 antagonist DHbE on memory persis-
tence could be observed. Further works concerning hippocampus
dependent eyeblink conditioning reported that a7 but no a4b2,
a3b2 ‘‘Knockouts’’ showed impairments on memory acquisition
(Brown, Comalli, Biasi, & Woodruff-Pak, 2010). Since the nAChR
subtypes a4b2, a3b2, and a7 show a distinct subcellular distribu-
tion and physiological roles, a a7 modulation of memorypersistence may be proposed, but further investigations are neces-
sary to prove this hypothesis (McKay et al., 2007; Zarei et al.,
1999).
We also demonstrated the role of the medial septum on mem-
ory persistence, as most of the cholinergic projections to the hippo-
campus originate in the medial septal nucleus and the vertical limb
nucleus of the diagonal band. Lesions or the inactivation of this re-
gion impairs memory (Fletcher, Calhoun, et al., 2006; Fletcher,
Baxter, et al., 2007; Janis, Glasier, Fulop, & Stein, 1998; Mizumori,
Perez, Alvarado, Barnes, & Mcnaughton, 1990; Niewiadomska
et al., 2009; Pang & Nocera, 1999; Pang, Nocera, Secor, & Yoder,
2001; Rashidy-Pour et al., 1996). Furthermore, Lecourtier and col-
laborators (2010) demonstrated that lesions made prior to the
training session on the septal cholinergic and GABAergic neurons
can hinder remote memory in animals trained in the Water Maze
Task. It was also observed that the formation of memory was not
affected 1 day after the training session, but was hindered after 5
or 25 days. Together with the data presented in this work this
information suggests a possible role for the medial septum on
the maintenance of the memories, not interfering in its formation
and thus reinforcing a possible activation of this area 12 h after
the acquisition (Lecourtier et al., 2010).
The uniformity on both anxiety levels and motor activity ob-
served in most of the treatments reinforces the reliability of the re-
sults obtained from the IA task, since alterations in such task could
interfere on the parameters involved in the evaluation of memory
retrieval. Though an increased motor activity was observed in the
group scopolamine tested 2 days after the training session, the re-
trieval of the memory was not affected, as the learning among the
animals was unaltered.
In conclusion, our ﬁndings suggest that mAChR and nAChR at
the CA1 area are required for the persistence of memory. In addi-
tion, the cholinergic medial septal nucleus, as well as M1 mAChR
subtype, but not nACHR a4b2, a3b2, participate in the memory
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